Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02298504
Other study ID # HP-00058711
Secondary ID
Status Active, not recruiting
Phase Phase 4
First received
Last updated
Start date July 1, 2018
Est. completion date February 2025

Study information

Verified date February 2024
Source University of Maryland, Baltimore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.


Description:

Pediatric patients having deep decay in primary molars seen at UMMC, UMSOD, and University of Maryland Rehabilitation and Orthopaedic Institute, will be included in the sample. Teeth with deep caries, >50% into dentin, will be randomly assigned using a table of random numbers to the three treatment groups: Group 1 pulpotomy with MTA, Group 2 pulpotomy with Biodentine, Group 3 indirect pulp treatment. Treatment will be performed by board certified pediatric dentists or they will directly supervise pediatric dental residents at each site as part of their regular protocol for treating deep caries. Radiographs will be taken as prescribed in the Guideline for taking Radiographs in Children by the American Academy of Pediatric Dentistry. Twice yearly clinical examinations will be performed by the treating dentists or pediatric dental residents to check for any soft tissue pathology such as abscess or mobility of treated tooth/teeth. If treatment success/failure consensus between the blinded dentists is not reached, a third dentist will be consulted. The success/failure data will be entered onto spreadsheets and examined statistically using statistical software.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 76
Est. completion date February 2025
Est. primary completion date February 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 9 Years
Eligibility Inclusion Criteria: - Pediatric patients with deep dental decay in primary molars - Teeth with signs and symptoms of reversible pulpitis Exclusion Criteria: - Teeth with clinical symptoms of irriversible pulpitis or pulp necrosis or acute dental infection - Children with systemic illness that contraindicated vital pulp treatment such a sickle cell disease - Teeth that are not restorable

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Mineral Trioxide Aggregate
Vital pulp therapy
Biodentin
Vital pulp therapy
Device:
Vitrebond
Vital pulp therapy

Locations

Country Name City State
United States University of Maryland School of Dentistry Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
University of Maryland, Baltimore

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical success after pulpotomy No signs of abscess or any swelling related to the tooth, no signs of fistula or other pathology, no signs of pathologic mobility, no post-operative pain, no pain on palpation or percussion of the tooth 3 years
Primary Clinical success after indirect pulp cap No signs of abscess or any swelling related to the tooth, no signs of fistula or other pathology, no signs of pathologic mobility, no post-operative pain, no pain on palpation or percussion of the tooth 3 years
Primary Radiographic success after pulpotomy No signs of root resorption (internal or external), no signs of furcation involvement or periapical radiolucency, no signs of loss of lamina dura, presence of normal appearance of periodontal ligament space 3 years
See also
  Status Clinical Trial Phase
Withdrawn NCT01878851 - Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.
Completed NCT04270318 - Sodium Hypoclorite as an Antibacterial Agent Prior to Pulpotomies N/A
Completed NCT04909827 - 3D-printed Endocrowns Versus Prefabricated Zirconia Crowns in Pulpally-treated Primary Molars Phase 4
Completed NCT03200938 - Clinical Applicability of PBS® CIMMO Cement in Pulpotomies N/A
Recruiting NCT04863222 - Clinical and Radiographic Success of MTA vs Biodentine Phase 4
Active, not recruiting NCT05554952 - Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries N/A
Completed NCT03779698 - BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars Phase 4
Completed NCT03395496 - Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up Early Phase 1
Not yet recruiting NCT05747300 - Wellroot PT Versus MTA in Pulpotomy of Primary Molars N/A
Not yet recruiting NCT06288477 - Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol N/A
Not yet recruiting NCT06219824 - Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars Phase 3
Completed NCT03718676 - Pulpotomy With Various MTA Materials and Ferric Sulphate N/A
Recruiting NCT05279820 - Comparative Study of the Outcome of Partial and Full Pulpotomy in Irreversible Pulpits N/A
Completed NCT04010929 - Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy N/A
Terminated NCT02783911 - Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies N/A
Withdrawn NCT02393326 - Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars N/A
Completed NCT05792748 - Comparison of Zinc Oxide Eugenol to Ferric Sulphate Pulpotomy in Primary Teeth N/A
Completed NCT05680285 - Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment N/A
Completed NCT05297344 - Clinical Study of the Direct Pulp Capping in Primary Teeth N/A
Completed NCT03782714 - Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies N/A